INS and Hypoglycemia: This real-world study shows that the odds of having a documented hypoglycaemia was higher in type 2 diabetes patients who initiated a conventional therapy (CT) with premixed insulin or were started on short acting insulin (SIT) than in those who began a basal insulin supported oral therapy (BOT).